CRT 2025

Technology and Innovation

BRS DES and DCB Technologies

Update on DynamX Bioadaptor from the INFINITY-SWEDEHEART Trial

Speaker(s)

• 

  David Erlinge, MD, PhD

  Professor, Consultant Interventional Cardiology
  Lund University
  Lund, Sweden

  Disclosure(s): No financial relationships to disclose